Hi, help us enhance your experience
Hi, help us enhance your experience
Hi, help us enhance your experience
811 Views
eMediNexus 26 December 2017
A double-blind, controlled, randomized trial compared the antihypertensive efficacy and safety of azilsartan with the angiotensin-converting enzyme inhibitor ramipril in patients with clinic systolic blood pressure (SBP) 150-180 mm Hg. In all, 884 patients were randomized to receive 20 mg azilsartan or 2.5 mg ramipril once daily for a period of 2 weeks, then force-titrated to 40 or 80 mg azilsartan or 10 mg ramipril for 22 weeks. The primary endpoint was change in trough, seated, clinic SBP. Mean patient age was 57±11 years. Mean baseline BP was 161.1±7.9/94.9±9.0 mm Hg. Clinic SBP was noted to fall by 20.6±0.95 and 21.2±0.95 mm Hg with azilsartan 40 and 80 mg vs. 12.2±0.95 mm Hg with ramipril. Adverse events leading to discontinuation were noted less frequently with azilsartan 40 and 80 mg (2.4% and 3.1%, respectively) in comparison with with ramipril (4.8%). Treatment of stage 1-2 hypertension was found to be more effective and better tolerated with azilsartan than ramipril. The findings were published in the Journal of Human Hypertension.
{{Article_Title}}
{{Article_Author}}
{{Article_Title}}
{{Article_Author}}
{{Article_Title}}..
High 1-hour Plasma Glucose: Early Indicator of Type 2 Diabetes Risk..
Maintaining Liver Health to Optimize Glycemic Outcomes in Early Type 2.....
Hidden Hazard of Indoor Pollution in COPD..
Antibiotic Prescribing Practices for Pediatric Acute Otitis Media..
Recognizing Pitfalls of Point-of-Care Lung Ultrasound..
{{Article_Title}}..
HMPV in India: Seven Cases Reported across Four States..
West Bengal Commission Fines Divine Nursing Home Rs 10 Lakh for Medical Negligence..
India Reports First Human Metapneumovirus (HMPV) Cases in Karnataka..
Two-Year-Old Dies after Wrong Injection Administered by Private Compounder in Jaisalmer..
'Law of the Land' Paramount for Blinkit's Ambulance Services, Says PiyushGoyal..